Quest Diagnostics Ownership | Who Owns Quest Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Quest Diagnostics Ownership Summary


Quest Diagnostics is owned by 91.19% institutional investors, 0.40% insiders, and 8.41% retail investors. Vanguard group is the largest institutional shareholder, holding 12.46% of DGX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Quest Diagnostics shares.

DGX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockQuest Diagnostics91.19%0.40%8.41%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryDiagnostics & Research Stocks47.99%9.06%42.96%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group13.96M12.46%$2.11B
Blackrock10.06M9.06%$1.38B
Blackrock funding, inc. /de10.12M9.04%$1.53B
Price t rowe associates inc /md/5.49M4.90%$828.26M
State street5.22M4.70%$787.72M
Victory capital management3.36M3.00%$506.89M
Geode capital management2.69M2.40%$404.76M
Jpmorgan chase2.43M2.17%$367.18M
Davis selected advisers2.40M2.16%$361.65M
Grantham, mayo, van otterloo2.27M2.03%$342.30M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ivy lane capital management57.00K4.64%$8.60M
Atwater malick55.14K2.79%$8.32M
Davis selected advisers2.40M2.10%$361.65M
Naples money management16.70K1.95%$2.29M
Jgp wealth management99.86K1.95%$15.06M
Fiduciary management inc /wi/1.30M1.83%$196.53M
Parkman healthcare partners90.35K1.82%$13.63M
Delta capital management20.79K1.79%$3.14M
Isthmus partners90.59K1.66%$13.67M
United bank89.16K1.51%$12.20M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/5.49M0.10%1.64M
Norges bank1.27M0.03%1.27M
Jpmorgan chase2.43M0.03%916.90K
Ubs group964.99K0.03%588.48K
Alliancebernstein1.09M0.06%498.00K

Top Sellers

HolderShares% AssetsChange
American century companies1.52M0.13%-764.96K
Nuance investments---681.64K
Blackrock10.06M0.03%-641.17K
Wellington management group llp1.78M0.05%-549.28K
8 knots management---497.61K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.27M0.03%1.27M$191.82M
Raymond james financial447.08K0.03%447.08K$67.45M
Foundry partners108.32K0.82%108.32K$16.34M
Edgestream partners27.69K0.18%27.69K$4.18M
Wbi investments27.68K1.04%27.68K$4.18M

Sold Out

HolderChange
Kozak & associates-1.00
Macroview investment management-2.00
Caitlin john-3.00
Gradient investments-3.00
Tfo-tdc-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20259636.41%101,224,9492.29%911.15%4525.12%32810.07%
Dec 31, 20248772.10%98,448,5932.51%881.21%4169.19%286-6.23%
Sep 30, 2024848-95,876,144-1.23%851.12%3795.57%3000.33%
Jun 30, 20248361.33%96,911,812-0.91%871.12%3531.15%294-5.47%
Mar 31, 2024825-2.14%97,800,2940.38%881.16%349-3.32%311-4.31%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.56M3.19%57.33K
Vanguard US Total Market Shares ETF3.51M3.17%2.60K
Vanguard Institutional 500 Index Trust3.14M2.81%50.08K
Vanguard Mid Cap Index Institutional2.41M2.16%23.09K
Sycamore Mid Cap Value Comp2.18M1.95%2.10M
Victory Sycamore Established Value R2.18M1.95%-210.00K
T. Rowe Price U.S. Large-Cap Core Tr-B1.57M1.41%47.37K
T. Rowe Price U.S. Large-Cap Core Tr-C1.57M1.40%47.37K
T. Rowe Price US Large-Cap Core Eq Comp1.47M1.32%-3.75K
T. Rowe Price US Large-Cap Core1.47M1.32%-958.00

Recent Insider Transactions


DateNameRoleActivityValue
May 13, 2025DELANEY MARK E SVP & Chief Commercial OfficerSell$153.22K
May 12, 2025DELANEY MARK E SVP & Chief Commercial OfficerSell$153.58K
Apr 02, 2025Davis J. E. CEO and PresidentSell$119.42K
Apr 02, 2025Davis J. E. CEO and PresidentSell$397.55K
Apr 02, 2025Davis J. E. CEO and PresidentSell$238.11K

Insider Transactions Trends


DateBuySell
2025 Q2-18
2025 Q1-12
2024 Q4-11
2024 Q3-3
2024 Q2-1

DGX Ownership FAQ


Who Owns Quest Diagnostics?

Quest Diagnostics shareholders are primarily institutional investors at 91.19%, followed by 0.40% insiders and 8.41% retail investors. The average institutional ownership in Quest Diagnostics's industry, Diagnostics & Research Stocks, is 47.99%, which Quest Diagnostics exceeds.

Who owns the most shares of Quest Diagnostics?

Quest Diagnostics’s largest shareholders are Vanguard group (13.96M shares, 12.46%), Blackrock (10.06M shares, 9.06%), and Blackrock funding, inc. /de (10.12M shares, 9.04%). Together, they hold 30.57% of Quest Diagnostics’s total shares outstanding.

Does Blackrock own Quest Diagnostics?

Yes, BlackRock owns 9.06% of Quest Diagnostics, totaling 10.06M shares as of Jun 2024. This represents 0.03% of BlackRock's total assets, with a market value of 1.38B$. In the last quarter, BlackRock decreased its holdings by -641K shares, a -5.99% change.

Who is Quest Diagnostics’s biggest shareholder by percentage of total assets invested?

Ivy lane capital management is Quest Diagnostics’s biggest shareholder by percentage of total assets invested, with 4.64% of its assets in 57K Quest Diagnostics shares, valued at 8.6M$.

Who is the top mutual fund holder of Quest Diagnostics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Quest Diagnostics shares, with 3.19% of its total shares outstanding invested in 3.56M Quest Diagnostics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools